EDN1 and myeloid sarcoma: Vasoactive agents such as nitric oxide and endothelin-1 that have profound, and often contrasting, effects on the vasculature are significantly raised within MS lesions (Smith and Lassmann, 2002, D’haeseleer et al., 2013).